These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 31440463)

  • 1. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine).
    De Francesco EM; Ózsvári B; Sotgia F; Lisanti MP
    Front Oncol; 2019; 9():615. PubMed ID: 31440463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs).
    Ozsvari B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2018 Feb; 10(2):229-240. PubMed ID: 29466249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs).
    Fiorillo M; Tóth F; Sotgia F; Lisanti MP
    Aging (Albany NY); 2019 Apr; 11(8):2202-2216. PubMed ID: 31002656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
    Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.
    Ozsvari B; Bonuccelli G; Sanchez-Alvarez R; Foster R; Sotgia F; Lisanti MP
    Aging (Albany NY); 2017 Dec; 9(12):2610-2628. PubMed ID: 29253841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs).
    De Francesco EM; Bonuccelli G; Maggiolini M; Sotgia F; Lisanti MP
    Oncotarget; 2017 Sep; 8(40):67269-67286. PubMed ID: 28978032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity.
    Sánchez-Alvarez R; De Francesco EM; Fiorillo M; Sotgia F; Lisanti MP
    Front Oncol; 2020; 10():1776. PubMed ID: 33194575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
    Ózsvári B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs).
    Fiorillo M; Lamb R; Tanowitz HB; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Aging (Albany NY); 2016 Aug; 8(8):1593-607. PubMed ID: 27344270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
    Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis.
    Ozsvari B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2017 Oct; 9(10):2098-2116. PubMed ID: 29080556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
    De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
    Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OXPHOS-targeting drugs in oncology: new perspectives.
    Kalyanaraman B; Cheng G; Hardy M; You M
    Expert Opin Ther Targets; 2023; 27(10):939-952. PubMed ID: 37736880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production.
    Fiorillo M; Tóth F; Brindisi M; Sotgia F; Lisanti MP
    Cells; 2020 Jun; 9(6):. PubMed ID: 32585919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.
    Bonuccelli G; Sotgia F; Lisanti MP
    Aging (Albany NY); 2018 Aug; 10(8):1867-1883. PubMed ID: 30153655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of natural products and FDA-approved drugs for targeting cancer stem cell (CSC) propagation.
    Bonuccelli G; Sotgia F; Lisanti MP
    Aging (Albany NY); 2022 Dec; 14(23):9466-9483. PubMed ID: 36455875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, Without Retaining Antibiotic Activity.
    Ózsvári B; Magalhães LG; Latimer J; Kangasmetsa J; Sotgia F; Lisanti MP
    Front Oncol; 2020; 10():1528. PubMed ID: 33042796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
    De Francesco EM; Sotgia F; Lisanti MP
    Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness".
    Bonuccelli G; De Francesco EM; de Boer R; Tanowitz HB; Lisanti MP
    Oncotarget; 2017 Mar; 8(13):20667-20678. PubMed ID: 28223550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity
    Sargiacomo C; Stonehouse S; Moftakhar Z; Sotgia F; Lisanti MP
    Front Oncol; 2021; 11():678343. PubMed ID: 34395247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.